Biomanufacturing scaling and supply chain resilience are top priorities for biopharma companies as they look to mitigate risks and capitalize on growth opportunities.
The certification reflects the company-wide integration of sustainability into supplier management and follows the CRDMO’s continued expansion of its manufacturing network.
